Tag: embolotherapy market share

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What External and Internal Drivers Are Contributing to the Growth of theEmbolotherapy Market?

The rising preference for minimally invasive procedures is expected to drive the growth of the embolotherapy market. Minimally invasive procedures, such as cosmetic treatments that require minimal surgical intervention, are becoming increasingly popular due to their quicker recovery times, reduced pain, and fewer complications. Embolotherapy enhances these procedures by targeting blood vessels, reducing bleeding, treating tumors, and managing vascular abnormalities with greater precision. As minimally invasive treatments grow, so does the demand for embolotherapy. For example, in September 2023, the American Society of Plastic Surgeons reported a 7% increase in cosmetic minimally invasive procedures, reaching over 25 million procedures. This growing trend of minimally invasive treatments is propelling the embolotherapy market forward.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21181&type=smp

#What Growth Opportunities Will Drive the Embolotherapy Market’s CAGR Through 2034?

The embolotherapy market has seen strong growth, expanding from $4.44 billion in 2024 to $4.86 billion in 2025 at a CAGR of 9.3%. The market’s growth has been driven by a rising demand for embolotherapy treatments, an increasing incidence of cancer, a higher prevalence of peripheral vascular diseases, growing healthcare expenditures, and increased investment in research.

The embolotherapy market is expected to witness substantial growth, reaching $6.83 billion by 2029 at a CAGR of 8.9%. Growth drivers include rising disposable incomes, an increasing prevalence of chronic diseases, greater adoption in reproductive health, a rise in chemoembolization procedures, and a growing incidence of liver cancer. Key trends include advancements in embolotherapy techniques, the development of digital and analog devices, innovations in insertable cardiac monitors, and strategic collaborations among industry players.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21181

Which Upcoming Market Trends and Innovations Are Set to Influence theEmbolotherapy Market’s Path Forward?

In the embolotherapy market, companies are innovating with absorbable embolic systems to improve treatment outcomes. These bioresorbable materials are used in embolization procedures to block blood flow to target tissues, gradually degrading within the body. For example, in January 2025, Instylla Inc., a US-based medical equipment manufacturer, received FDA 510(k) clearance for its Tembo embolic system, which uses irregularly shaped dry-gelatin particles for embolizing hypervascular tumors and occluding blood vessels. Tembo offers advantages such as easy preparation and high visibility, potentially improving outcomes compared to permanent embolic solutions.

Who Are the Dominant Market Players Pushing the Boundaries of theEmbolotherapy Market?

Major companies operating in the embolotherapy market are Boston Scientific Corporation, Terumo Medical Corporation , Medtronic PLC, Johnson And Johnson, Stryker Corporation, Sirtex Medical, Abbott Laboratories, Acandis GmbH, Balt Group LLC, Penumbra Inc, Merit Medical Systems, Kaneka Corporation, Meril Life Sciences Pvt. Ltd., Shape Memory Medical Inc, Guerbet, IMBiotechnologies Ltd, Cardiva , Rapid Medical, Emboline Inc, Microport Scientific, Inari Medical, Instylla Inc, Embolx Inc, GE Healthcare, Lepu Medical Technology Co Ltd, WEGO HEALTHCARE (SHENZHEN) CO., LTD, Achieva Medical Inc, Varian Medical Syatems Inc

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/embolotherapy-global-market-report

What Are the Core Segments of the Embolotherapy Market, and How Do They Contribute to Growth?

The embolotherapy market covered in this report is segmented –

1) By Product: Embolization Coil, Embolic Agents, Detachable Balloons, Embolic Plug Systems, Support Devices

2) By Application: Oncology, Peripheral Vascular Diseases, Urology and Nephrology, Neurology, Gastrointestinal (GIT) Disorders

3) By Procedure: Transcatheter Arterial Embolization (TAE), Transcatheter Arterial Radioembolization (TARE) Or Selective Internal Radiation Therapy (SIRT), Transarterial Chemoembolization (TACE)

4) By End User: Ambulatory Surgical Centre, Hospitals And Clinics, Other End Users

Subsegments:

1) By Embolization Coil: Bare Coils, Coated Coils, Micro Coils

2) By Embolic Agents: Liquid Embolic Agents, Particulate Embolic Agents, Gelatin Sponge, Polyvinyl Alcohol (PVA) Particles

3) By Detachable Balloons: Single-Use Balloons, Multi-Use Balloons

4) By Embolic Plug Systems: Plug Kits, Distal Occlusion Systems

5) By Support Devices: Guidewires, Catheters, Sheath Introducers

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=21181&type=smp

What Regions Are Dominating the Embolotherapy Market Growth?

North America was the largest region in the embolotherapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the embolotherapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Embolotherapy Market 2025, By The Business Research Company:

Migraine Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/migraine-global-market-report

Migraine Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/migraine-treatment-global-market-report

Infection Control Global Market Report 2025

https://thebusinessresearchcompany.com/report/infection-control-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

How has the embolotherapy market grown over the years?

The embolotherapy sector has seen robust expansion in its size in previous years. It is projected to rise from $4.44 billion in 2024 to $4.86 billion in 2025, marking a compound annual growth rate (CAGR) of 9.3%. The significant growth during the historical period is due to the escalating demand for embolotherapy treatments, a surge in cancer occurrences, an uptick in peripheral vascular disease cases, increased healthcare spending, and intensified research investment.

What Is the forecasted market size and growth rate for the embolotherapy market?

Predictions for the embolotherapy market size suggest substantial growth in the coming years. The market is set to expand to the value of $6.83 billion by 2029, with a compound annual growth rate (CAGR) of 8.9%. Factors contributing to this upward trajectory during the forecast period include an increase in disposable income, a rise in the occurrence of chronic diseases, heightened usage in reproductive health, an increasing amount of cheoembolization procedures, and a growing number of liver cancer cases. Key trends that can be expected within the forecast period consist of advanced technologies, digital and analog devices, insertable cardiac monitors, embolotherapy techniques, and strategic partnerships.

Get your embolotherapy market report here!

https://www.thebusinessresearchcompany.com/report/embolotherapy-global-market-report

What are the major factors driving growth in the embolotherapy market?

The embolotherapy market’s growth is anticipated to be fueled by the increasing inclination towards minimally invasive procedures. These are cosmetic treatments that mostly eliminate the need for surgery, involve brief recovery periods and carry fewer risks. The escalating popularity of these procedures is spurred by factors such as quicker recovery times, less pain, minimal scarring, decreased risk of complications, and technological advancements. Embolotherapy strengthens minimally invasive treatments by specifically hindering blood flow to target vessels, reducing hemorrhaging, treating tumors, and dealing with vascular anomalies with enhanced accuracy and reduced complications. For example, the American Society of Plastic Surgeons, a non-profit organization in the US, reported in September 2023 that cosmetic minimally invasive procedures escalated by 7% in 2023, reaching 25,442,640 from 23,672,269 in 2022. Hence, the rising popularity of minimally invasive treatments is propelling the expansion of the embolotherapy market.

What key areas define the segmentation of the global embolotherapy Market?

The embolotherapy market covered in this report is segmented –

1) By Product: Embolization Coil, Embolic Agents, Detachable Balloons, Embolic Plug Systems, Support Devices

2) By Application: Oncology, Peripheral Vascular Diseases, Urology and Nephrology, Neurology, Gastrointestinal (GIT) Disorders

3) By Procedure: Transcatheter Arterial Embolization (TAE), Transcatheter Arterial Radioembolization (TARE) Or Selective Internal Radiation Therapy (SIRT), Transarterial Chemoembolization (TACE)

4) By End User: Ambulatory Surgical Centre, Hospitals And Clinics, Other End Users

Subsegments:

1) By Embolization Coil: Bare Coils, Coated Coils, Micro Coils

2) By Embolic Agents: Liquid Embolic Agents, Particulate Embolic Agents, Gelatin Sponge, Polyvinyl Alcohol (PVA) Particles

3) By Detachable Balloons: Single-Use Balloons, Multi-Use Balloons

4) By Embolic Plug Systems: Plug Kits, Distal Occlusion Systems

5) By Support Devices: Guidewires, Catheters, Sheath Introducers

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21181&type=smp

What are the top market players propelling the growth of the embolotherapy industry?

Major companies operating in the embolotherapy market are Boston Scientific Corporation, Terumo Medical Corporation , Medtronic PLC, Johnson And Johnson, Stryker Corporation, Sirtex Medical, Abbott Laboratories, Acandis GmbH, Balt Group LLC, Penumbra Inc, Merit Medical Systems, Kaneka Corporation, Meril Life Sciences Pvt. Ltd., Shape Memory Medical Inc, Guerbet, IMBiotechnologies Ltd, Cardiva , Rapid Medical, Emboline Inc, Microport Scientific, Inari Medical, Instylla Inc, Embolx Inc, GE Healthcare, Lepu Medical Technology Co Ltd, WEGO HEALTHCARE (SHENZHEN) CO., LTD, Achieva Medical Inc, Varian Medical Syatems Inc

What emerging trends are influencing the growth of the embolotherapy market?

Leading participants in the embolotherapy market are emphasizing the development of innovative products such as dissolvable embolic apparatus to improve patient results and diversify treatment solutions. Dissolvable embolic devices make use of bioresorbable substances in embolization procedures to curtail blood supply to desired tissues like tumors or aneurysms, and they eventually decompose within the body. In January 2025, for instance, Instylla Inc., a medical equipment producer based in the United States, gained U.S. Food and Drug Administration (FDA) 510(k) approval for its Tembo embolic mechanism. This is a bioresorbable agent for embolization composed of unevenly shaped, dry-gelatin particles, ranging from 85 to 255 µm. The Tembo system is purposed to embolize hypervascular tumours and to block blood vessels in the peripheral vasculature. Instylla reports that Tembo provides benefits including straightforward preparation, excellent visibility, and capacity to fill treated vessels densely, offering possible enhancements to existing permanent embolic interventions.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21181

What regions are dominating the embolotherapy market growth?

North America was the largest region in the embolotherapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the embolotherapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Migraine Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/migraine-global-market-report

Migraine Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/migraine-treatment-global-market-report

Infection Control Global Market Report 2025

https://thebusinessresearchcompany.com/report/infection-control-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How Significant is the Anticipated Growth Rate of the Embolotherapy Market from 2025 to 2034?

The size of the embolotherapy market has seen robust growth in the past few years. Its size is predicted to expand from $4.44 billion in 2024 and surge to $4.86 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 9.3%. Factors contributing to the growth during the historical period include increased use of embolotherapy for treatment purposes, a rise in cancer cases, a heightened incidence of peripheral vascular diseases, a boost in healthcare spending, and enhanced investment towards research.

Expectations are high for robust expansion in the embolotherapy market in the coming years, with the market size projected to reach $6.83 billion in 2029, reflecting an 8.9% compound annual growth rate (CAGR). The growth anticipated during the forecast period can be credited to several factors such as an increase in disposable income, a rise in chronic disease cases, increased utilization in reproductive health, a surge in the number of cheoembolization procedures, and a heightened incidence of liver cancer. Key trends set to characterize the forecast period encompass advanced technologies, both digital and analog devices, insertable cardiac monitors, methodologies of embolotherapy, and strategic collaboration efforts.

What Drivers Are Shaping the Growth of the Embolotherapy Market?

The embolotherapy market’s expansion is anticipated due to an increasing affinity towards minimally invasive procedures. Such procedures, characterized by minimal to no surgical intervention, are mostly cosmetic treatments. Concepts like speedy recovery, diminished pain, lesser scars, decreased risks of complications, and technological evolution contribute to their rising preference. The enhancement of these minimally invasive procedures is made possible by embolotherapy, which ensures specified blockage of blood supply to the intended vessels, leading to lowered bleeding, efficient tumor treatments, and better management of vascular disparities with more accuracy and lesser complications. As attested by the American Society of Plastic Surgeons, a non-profit US-based organization, there was a surge of 7% in cosmetic minimally invasive procedures in September 2023, with the number escalating to 25,442,640 from its previous recorded figure of 23,672,269 in 2022. Therefore, the enhancing preference for minimally invasive procedures fuels the growth of the embolotherapy market.

Get Your Free Sample of the Global Embolotherapy Market Report Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=21181&type=smp

Who Are the Dominant Players Pushing the Boundaries of the Embolotherapy Market?

Major companies operating in the embolotherapy market are Boston Scientific Corporation, Terumo Medical Corporation , Medtronic PLC, Johnson And Johnson, Stryker Corporation, Sirtex Medical, Abbott Laboratories, Acandis GmbH, Balt Group LLC, Penumbra Inc, Merit Medical Systems, Kaneka Corporation, Meril Life Sciences Pvt. Ltd., Shape Memory Medical Inc, Guerbet, IMBiotechnologies Ltd, Cardiva , Rapid Medical, Emboline Inc, Microport Scientific, Inari Medical, Instylla Inc, Embolx Inc, GE Healthcare, Lepu Medical Technology Co Ltd, WEGO HEALTHCARE (SHENZHEN) CO., LTD, Achieva Medical Inc, Varian Medical Syatems Inc

How Are Market Trends Revolutionizing the Embolotherapy Industry in Recent Times?

In the embolotherapy sector, leading firms are prioritizing the creation of novel products such as absorbable embolics systems to improve patient results and diversify treatment possibilities. Absorbable embolic systems pertain to biodegradable materials that are utilized in embolization processes to inhibit blood supply to specific tissues like tumors or aneurysms, while slowly disintegrating in the body over time. Take for example, Instylla Inc., a medical equipment manufacturer based in the U.S., which was granted U.S. Food and Drug Administration (FDA) 510(k) clearance for its Tembo embolic system in January 2025. This system, composed of sporadically shaped, dry-gelatin particles between 85 and 255 µm, is a bioresorbable embolization agent. It has been engineered to embolize hypervascular tumors and occlude blood vessels in the peripheral vasculature. According to Instylla, the Tembo system provides benefits such as simple preparation, excellent visibility, and the capacity to densely fill treated vessels, which could potentially enhance existing permanent embolic solutions.

Get Instant Access to the Global Embolotherapy Market Report with Swift Delivery!

https://www.thebusinessresearchcompany.com/report/embolotherapy-global-market-report

How Are the Key Segments of the Embolotherapy Market Driving Opportunities and Innovations?

The embolotherapy market covered in this report is segmented –

1) By Product: Embolization Coil, Embolic Agents, Detachable Balloons, Embolic Plug Systems, Support Devices

2) By Application: Oncology, Peripheral Vascular Diseases, Urology and Nephrology, Neurology, Gastrointestinal (GIT) Disorders

3) By Procedure: Transcatheter Arterial Embolization (TAE), Transcatheter Arterial Radioembolization (TARE) Or Selective Internal Radiation Therapy (SIRT), Transarterial Chemoembolization (TACE)

4) By End User: Ambulatory Surgical Centre, Hospitals And Clinics, Other End Users

Subsegments:

1) By Embolization Coil: Bare Coils, Coated Coils, Micro Coils

2) By Embolic Agents: Liquid Embolic Agents, Particulate Embolic Agents, Gelatin Sponge, Polyvinyl Alcohol (PVA) Particles

3) By Detachable Balloons: Single-Use Balloons, Multi-Use Balloons

4) By Embolic Plug Systems: Plug Kits, Distal Occlusion Systems

5) By Support Devices: Guidewires, Catheters, Sheath Introducers

Which Geographic Areas Are Influencing the Growth of the Embolotherapy Market?

North America was the largest region in the embolotherapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the embolotherapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Core Features That Define the Embolotherapy Market?

Embolotherapy is a minimally invasive medical procedure involving intentionally blocking blood vessels to treat various medical conditions. It is achieved by injecting embolic agents, such as microspheres, coils, gels, or liquid embolic, into targeted blood vessels to cut off blood supply to abnormal tissues or structures. Embolotherapy is a highly targeted and less invasive alternative to traditional surgery, often performed by interventional radiologists to improve patient outcomes with minimal recovery time.

Browse Through More Similar Reports By The Business Research Company:

Migraine Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/migraine-global-market-report

Migraine Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/migraine-treatment-global-market-report

Infection Control Global Market Report 2025

https://thebusinessresearchcompany.com/report/infection-control-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: